InsiderOther
James Peyer Insider Trading Activity
Every SEC Form 4 transaction reported by James Peyer, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is James Peyer buying or selling?
James Peyer reported 47 open-market buys ($4.2M) and 3 sells ($787.8K) across 50 Form 4 filings at 1 company — a net buying position of $3.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 1, 2026)
Total Form 4 filings
50
SEC EDGAR
Companies
1
Buys (47)
$4.2M
Sells (3)
$787.8K
Insider sentiment
Net buyingNet insider flow of $3.4M in net buying, filed between Feb 19, 2021 – Jun 1, 2026.
Companies James Peyer files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | SNSESensei Biotherapeutics, Inc. | 50 |
Recent James Peyer transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | SNSE | Other, 10% Owner | Sale | 25.0K | $500.5K |
| Dec 10, 2025 | SNSE | Other, 10% Owner | Sale | 6.6K | $54.6K |
| Dec 8, 2025 | SNSE | Other, 10% Owner | Sale | 21.3K | $232.7K |
| Jun 10, 2022 | SNSE | Director, 10% Owner | Purchase | 1.2K | $3.8K |
| Apr 21, 2022 | SNSE | Director, 10% Owner | Purchase | 9.5K | $136.2K |
| Apr 21, 2022 | SNSE | Director, 10% Owner | Purchase | 752 | $14.9K |
| Mar 2, 2022 | SNSE | Director, 10% Owner | Purchase | 1.2K | $3.8K |
| Mar 1, 2022 | SNSE | Director, 10% Owner | Purchase | 2.5K | $9.0K |
| Feb 28, 2022 | SNSE | Director, 10% Owner | Purchase | 2.5K | $9.1K |
| Feb 25, 2022 | SNSE | Director, 10% Owner | Purchase | 17.5K | $64.0K |
| Feb 22, 2022 | SNSE | Director, 10% Owner | Purchase | 19.9K | $80.2K |
| Feb 16, 2022 | SNSE | Director, 10% Owner | Purchase | 12.6K | $52.6K |
| Feb 15, 2022 | SNSE | Director, 10% Owner | Purchase | 17.5K | $77.9K |
| Feb 8, 2022 | SNSE | Director, 10% Owner | Purchase | 30.0K | $135.8K |
| Jan 31, 2022 | SNSE | Director, 10% Owner | Purchase | 15.0K | $63.8K |
| Jan 27, 2022 | SNSE | Director, 10% Owner | Purchase | 50.0K | $235.8K |
| Jan 25, 2022 | SNSE | Director, 10% Owner | Purchase | 47.4K | $228.5K |
| Jan 21, 2022 | SNSE | Director, 10% Owner | Purchase | 30.2K | $154.3K |
| Jan 20, 2022 | SNSE | Director, 10% Owner | Purchase | 10.0K | $50.8K |
| Jan 18, 2022 | SNSE | Director, 10% Owner | Purchase | 26.2K | $133.4K |
| Jan 13, 2022 | SNSE | Director, 10% Owner | Purchase | 20.0K | $104.2K |
| Jan 11, 2022 | SNSE | Director, 10% Owner | Purchase | 10.0K | $52.8K |
| Jan 3, 2022 | SNSE | Director, 10% Owner | Purchase | 1.1K | $5.5K |
| Dec 30, 2021 | SNSE | Director, 10% Owner | Purchase | 69.0K | $343.6K |
| Dec 29, 2021 | SNSE | Director, 10% Owner | Purchase | 11.3K | $59.6K |
Showing the 25 most recent filings of 50. Screen every filing.
James Peyer insider trading FAQ
Is James Peyer buying or selling?
Across 50 SEC Form 4 filings, James Peyer reported 47 open-market purchases totaling $4.2M and 3 sales totaling $787.8K — a net buying position of $3.4M.
Which companies does James Peyer file Form 4s for?
James Peyer has reported insider transactions at 1 company, most often Sensei Biotherapeutics, Inc. (SNSE).
How far back does James Peyer's filing history go?
Trabud holds James Peyer's SEC Form 4 filings from Feb 19, 2021 – Jun 1, 2026, sourced directly from SEC EDGAR.
Where does Trabud get James Peyer's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track James Peyer and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener